References
- Porter S. Human immune response to recombinant human proteins. J Pharm Sci 2001;90:1–11
- Koren E. From characterization of antibodies to prediction of immunogenicity. Dev Biol 2002;109:87–95
- Casadevall N, Nataf J, Viron B, et al. Pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin. N Engl J Med 2002;346:469–75
- Swanson SJ, Mytych D, Ferbas J. Use of biosensors to monitor the immune response. Devel Biol 2002;109:71–8
- Swanson SJ. New technologies for the detection of antibodies to therapeutic proteins. Dev Biol 2003;112:127–33
- Findlay JWA, Smith WC, Lee JW, et al. Validation of immunoassays for bioanalysis: a pharmaceutical industry perspective. J Pharm Biomed Anal 2000;21:1249–73
- Jönsson U, Fägerstam LG, Ivarsson B, et al. Real-time biospecific interaction analysis using surface plasmon resonance and a sensor chip technology. Biotechniques 1991;11:620–7
- Van Regenmortel MH. Use of biosensors to characterize recombinant proteins. Dev Biol Standards 1994;83:143–51
- Malmqvist M, Karlsson R. Biomolecular interaction analysis: affinity biosensor technologies for functional analysis of proteins. Curr Opin Chem Biol 1997;1:378–83
- Schuck P. Use of surface plasmon resonance to probe the equilibrium and dynamic aspects of interactions between biological macromolecules. Annu Rev Biophys Biomol Struct 1997;26:541–66
- Pearson JE, Kane JW, Petraki-Kallioti I, Gill A, Vadgama P. Surface plasmon resonance: a study of the effect of biotinylation on the selection of antibodies for use in immunoassays. J Immunol Methods 1998;221:87–94
- Fägerstam LG, Frostell Å, Karlsson R, et al. Detection of antigen-antibody interactions by surface plasmon resonance. Application to epitope mapping. J Mol Recognit 1990;3:208–14
- Ohlson S, Strandh M, Nilshans S. Detection and characterization of weak affinity antibody-antigen recognition with biomolecular interaction analysis. J Mol Recognit 1997;10:135–8
- Van Regenmortel MH, Altschuh D, Chatellier L, et al. Measurements of antigen-antibody interactions with biosensors. J Mol Recognit 1998;11:163–7
- Huber A, Demartis S, Neri D. The use of biosensor technology for the engineering of antibodies and enzymes. J Mol Recognit 1999;12:198–216
- Wong R, Mytych D, Jacobs S, Borden R, Swanson SJ. Validation parameters for a novel biosensor assay which simultaneously measures serum concentrations of a humanized monoclonal antibody and detects induced antibodies. J Immunol Methods 1997;209:1–15